In addition, the expression of PD-1/PD-L1, but not PD-L2, on peripheral blood mononuclear cells (PBMC) was significantly downregulated in patients with MS compared with healthy controls (Javan et al., 2016). This evidence concerns the gene PDCD1 and myeloid sarcoma.